Abstract: The wireless communication terminal transmits acquired data by wireless communication. The gateway device receives the data from the wireless communication terminal. The polling device performs polling to the gateway device to control data reception of the gateway device from the wireless communication terminal. Also, the pooling device receives the data that the gateway device received from the wireless communication terminal from the gateway device. The server device controls activation and stop of the polling device. The server device receives the data that the polling device received from the gateway device.

Abstract: A method as disclosed herein generates objective projections of aggregate costs from a plurality of providers associated with different aspects of a healthcare procedure. An interface is selectively initiated with a first provider associated with a patient and a respective healthcare procedure. A data module is established for the patient based on projected cost data for aspects associated with the first provider for the procedure. Respective interfaces are selectively initiated between further providers and the hosted platform, wherein each interface receives projected cost data for aspects associated with the respective provider for the procedure. Upon determining a threshold amount of cost data has been received for each of the different aspects of the procedure, the platform enables selective access by the patient to an aggregated cost projection for the procedure, based entirely on the input data received by the hosted platform for the respective healthcare procedure.

Abstract: The present invention is directed to a prolipid composition that penetrates the stratum corneum. More particularly, the invention is directed to a prolipid composition that provides personalized benefits by rapidly restoring the skins natural lipid balance. Such a composition results in elongated fatty acid and/or lipid production deep in the stratum corneum and near the surface of the stratum lucidum. The composition at least comprises a fatty acid, fatty ester and/or an acylglycerol and an activator of a peroxisome proliferator-activated receptor.

Abstract: A fabric conditioner composition comprising: a) fabric softening active; and b) ingredient comprising at least one ethoxylate unit and at least one carbon derived from carbon capture.

Abstract: Disclosed is a personal care composition providing anti-inflammation benefits. The composition comprises a Moringa extract and a hydroxy fatty acid, wherein the weight ratio of the Moringa extract to the hydroxy fatty acid is from 1:1 to 75:1.

Abstract: A laundry liquid composition comprising at least 50% wt. water, an alkyl ether sulphate surfactant and an alcohol ethoxylate surfactant, wherein at least one of the alkyl ether sulphate and alcohol ethoxylate comprises at least 10% weight C16/18 alkyl chains and a dye.

Abstract: A personal tactical system including a load-bearing garment, a pouch with one or more batteries enclosed in the pouch, at least one power distribution and data hub, and at least one camera. The camera is incorporated into or removably attachable to the load-bearing garment, the pouch is removably attachable to the load-bearing garment and the one or more batteries are operable to supply power to the at least one power distribution and data hub. The at least one power distribution and data hub is operable to supply power to at least one peripheral device. A plurality of personal tactical systems is operable to form an ad hoc network to share images and other information for determining object direction, location, and movement.

Abstract: Hematopoietic stem/progenitor cells (HSPC) and/or non-T effector cells are genetically modified to express (i) an extracellular component including a ligand binding domain that binds a cellular marker preferentially expressed on an unwanted cell; and (ii) an intracellular component comprising an effector domain. Among other uses, the modified cells can be administered to patients to target unwanted cancer cells without the need for immunological matching before administration.

Abstract: The information processing device according to the third embodiment includes a determination means and a transmission means. The determination means determines a state of a target animal based on a physical quantity of information related to movement or behavior of the target animal. The transmission means transmits message information corresponding to the determined state to a terminal device.

Abstract: A pressure containment assembly for use with a plurality of sensor assemblies for monitoring a parameter within a pressure vessel is disclosed. The pressure containment assembly includes a primary seal plate to seal against pressure in the pressure vessel and a plurality of passageways to receive the sensor assemblies. The containment assembly also includes a secondary seal cap connected to the process plate and covering the passageways. The seal cap includes a recessed region that is oriented such that, when the seal cap is sealed to the primary seal plate, the recessed region creates a sealed pressure containment chamber.

Abstract: a savoury flavour concentrate from seaweed provides for umami and meaty notes when added to savoury food product. The concentrate can be used for the preparation of flavour products or can be added as such. Also described is a process for the preparation of the concentrate from seaweed by boiling seaweed, removing it from the boiling water, and further concentrating the remaining liquid.

Abstract: Disclosed embodiments include apparatuses, systems, and methods for providing an atraumatic sheath tip. Various disclosed embodiments seek to help reduce or avoid unnecessary tissue damage upon a sheath being extended to convey an elongated instrument for sampling or treatment. In an illustrative embodiment, an apparatus includes a deformable sheath tip configured to be positioned at a distal end of a sheath. The sheath defines therein a lumen configured to convey an elongated instrument. The sheath tip has a base end disposable at the distal end of the sheath and a contact end. The sheath tip has a first column strength along an axis of the sheath tip that is less than a second column strength of the sheath and a first degree of deformability that is greater than a second degree of deformability of the sheath.

Abstract: Soap composition comprising (i) saponified fatty matter made from a fat blend comprising lauric fatty acid and saturated and unsaturated non-lauric fatty acids, the iodine value being from 44 to 58 g iodine per 100 g of said saponified fatty matter; and (ii) a hydrogel which is non-thermoreversible at 70 to 140° C. Disclosed is also a bar of soap comprising the soap composition and a process of preparing the soap composition.

Abstract: Disclosed is a hair care composition comprising a (i) an anionic surfactant; (ii) an amphoteric or zwitterionic surfactant; (iii) piroctone olamine; iv) a polyaspartate or its derivative presented by the structure of formula (1), where the sum of m+n is from 2 to 10000, R1, R2 are independently selected from the group consisting of H, OH, (O)mG, m is 0 or 1, G is independently selected from the group consisting of H and a substituted or unsubstituted C1-C12 organic group, ammonium salt, wherein non-limiting examples of the metal salts include Na, K, Ca, Mg, Al salts; and v) a cosmetically acceptable carrier; wherein the weight ratio of said polyaspartate or its derivative to said piroctone olamine in the composition is at least 2:3. It has been shown to improve the stability of the piroctone olamine.

Abstract: The present disclosure relates to biomarker profiles and their use to predict a subject's response to an immunomodulatory treatment. Biomarkers in these profiles include cytokines and other proteins associated with the interleukin 1 family and the type 1 interferon family. Particular biomarkers include interleukin (IL)-2, soluble IL-2 receptor alpha (sIL-2RA), IL-5, IL-6, IL-9, IL-10, IL-18, IL-18 binding protein (IL-18BP), IL-18 receptor 1 (IL-18R1), IL-18 receptor accessory protein (IL-18RAP), IL-22, C-type lectin-like receptor (CD161), CD56, interferon gamma (IFN?), granulocyte macrophage colony stimulating factor (GM-CSF), serum amyloid A (SAA), and C-reactive protein (CRP). Particular biomarkers also include populations of cells including CD161+ cells and CD56+dim cells. The biomarker profiles can be used to predict a subject's responsiveness to an immunomodulatory treatment (e.g.

Abstract: The invention concerns an oleyl alcohol, wherein the oleyl chain is obtained from a mixture of 1:9 to 6:4, preferably 2:8 to 5:5 of oil (1):oil (2) by hydrogenation of a fatty acid, a fatty acid methyl ester or a combination thereof to provide a fatty alcohol, where oil (1) is selected from palm oil, cottonseed oil or a mixture thereof, and oil (2) is selected from tall oil, olive oil, low erucic rapeseed oil, sunflower seed oil variants containing greater than 60 wt. % oleic acid or mixtures thereof; and a process to make said oleyl alcohol.

Abstract: The invention is a portable, climate controlled housing for sampling instrumentation having an outer housing and an insulted interior housing for receiving the sampling instrumentation, a sampling hose is connectable from the instrumentation to outside of the housing, a thermoelectric cooler device is provided within the outer housing to cool the interior of the outer housing, one or more exhaust fan are provided to remove air from inside the outer housing, a temperature probe is disposed within the interior insulated housing and a thermostat is operably connected to the exhaust fan, the cooler device and the temperature probe so that when the interior temperature of the insulated housing is detected to be outside a preferred range, the thermoelectric cooler device and the exhaust fan are operated until the interior temperature within the insulated housing is within a preferred range.

Abstract: The invention provides a natural killer cell, NK-92, modified to express an Fc receptor on the surface of the cell, such as CD16 (Fc?RIII-A), or other Fc? or Fr receptors. The modified NK-92 cell can be further modified to concurrently express an associated accessory signaling protein, such as Fc?RI-?, TCR-?, or to concurrently express interleukin-2 (IL-2) or other cytokines. Additional methods are disclosed for various assays, assessments, and therapeutic treatments with the modified NK-92 cells.

Abstract: A cleansing composition includes 25% to 35% by weight of a surfactant, 1.5% to 5% by weight of a co-surfactant, 5% to 9% by weight of water; and 50% to 60% by weight of a fatty acid and soap mixture, wherein the fatty acid to soap ratio is 2.3:1 to 1.8:1. A method of making cleansing bars includes heating the cleansing composition to a temperature sufficient to provide a molten composition, cooling the molten composition to form flakes and/or chips, refining the flakes and/or chips to form billets, and stamping and/or cutting the billets to form the cleansing bars. Another method of making cleansing bars includes heating the cleansing composition to a temperature sufficient to provide a molten composition, pouring the molten composition into a mold, cooling the molten composition until the cleansing bars are formed, and removing the cleansing bars from the mold.

Abstract: Devices, systems and methods for a cloud-based meter management system are provided. The present disclosure includes a meter cloud server, a plurality of IEDs or meters, and one or more clients 608 (e.g., a web browser client), which are coupled together via a network (e.g., via various wireless and/or hardwired communication networks). The various components and modules of the present disclosure provide a plurality of functions to enable one or more users to manage a plurality of IEDs or meters via the at least one client device.